Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Capabilities now include R&D and TOX lot formulation and filling.
September 14, 2022
By: Tim Wright
Editor-in-Chief, Contract Pharma
Following their recent expansion into formulation, method and lyo development, Berkshire Sterile Manufacturing (BSM) now offers two new services to assist their clients in their R&D efforts as they head towards clinical development and trials. “We’ve had several clients that needed R&D material for chemical stability testing and to perform higher quality TOX studies and we are thrilled to announce that we expanded our facility and team to finally offer this service in house,” said Tyne Jeffrey, vice president of sales, BSM. Short-term production of non-sterile drug products is critical to supplying R&D work—a necessary step to developing a new drug product candidate. Though BSM was initially founded to support the production of clinical study material and commercial products, they have recently expanded into offering services to support those that have not yet stepped out of R&D and into pre-clinical studies. BSM offers significant development support and will now perform non-GMP engineering runs to produce material for R&D. These non-GMP runs simulate real GMP manufacturing and serve two significant purposes: to supply study material and to serve as early engineering runs to develop a successful GMP manufacturing process. BSM’s chief technical officer and co-founder, Dr. Andrea Wagner, said, “Understanding the client’s needs and working with them at these early stages is helpful to getting them into the clinic faster. It also reduces the risk of formulation failures since our team will already understand all the materials and technology that will be used during their cGMP campaign.” These new services are offered at reduced cost compared to full-scale engineering runs, and it provides some similar technologies. Small volumes for animal studies or quick stability assessments can be performed quickly and cost effectively. BSM utilizes only isolator-based filling and aseptic formulation. BSM was founded in July of 2014, has undergone five FDA inspections, and has consistently expanded and improved its site, staff, and services. Their mission is to provide the highest quality drug products achievable. BSM serves companies of all sizes from development through commercial parenteral filling and formulation.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !